Previous studies showed that FADS2 was associated with many biological processes and several diseases including NAFLD and CAD, and this association could be mediated by regulating LC-PUFA metabolism. The gene discussed is FADS2; the disease is metabolic dysfunction-associated steatotic liver disease.